Suchergebnisse
Katalog
Aufsätze & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- pharmaceutical industry 28 Treffer
- alexion pharmaceuticals inc. 27 Treffer
- swot analysis 18 Treffer
- alexza pharmaceuticals inc. 15 Treffer
- clinical trials 8 Treffer
-
45 weitere Werte:
- drug development 8 Treffer
- bipolar disorder 5 Treffer
- schizophrenia treatment 5 Treffer
- agitation (psychology) 4 Treffer
- business cycles 4 Treffer
- business finance 4 Treffer
- corporate growth 4 Treffer
- corporate profits 4 Treffer
- corporations 4 Treffer
- drug efficacy 4 Treffer
- financial performance 4 Treffer
- industrial location 4 Treffer
- therapeutics 4 Treffer
- revenue 3 Treffer
- biovail laboratories international srl 2 Treffer
- clinical drug trials 2 Treffer
- medical research 2 Treffer
- novartis ag 2 Treffer
- people with schizophrenia 2 Treffer
- schizophrenia 2 Treffer
- united states. food & drug administration 2 Treffer
- albany molecular research inc. 1 Treffer
- allergens 1 Treffer
- antiasthmatic agents 1 Treffer
- autoimmune diseases 1 Treffer
- bayer healthcare pharmaceuticals inc. 1 Treffer
- biotechnology industries 1 Treffer
- bristol-myers squibb co. 1 Treffer
- business partnerships 1 Treffer
- business success 1 Treffer
- central nervous system diseases 1 Treffer
- cephalon inc. 1 Treffer
- clinical medicine research 1 Treffer
- cypress bioscience inc. 1 Treffer
- drug approval 1 Treffer
- drug patents 1 Treffer
- drugs 1 Treffer
- economic competition 1 Treffer
- endo pharmaceuticals inc. 1 Treffer
- european commission 1 Treffer
- immune response 1 Treffer
- immunoglobulins 1 Treffer
- industries 1 Treffer
- janssen pharmaceuticals inc. 1 Treffer
- johnson & johnson pharmaceutical research & development llc 1 Treffer
Publikation
Sprache
Geographischer Bezug
Inhaltsanbieter
42 Treffer
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2023-09-28, S. 1-6Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2023-08-17, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2023-07-31, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2023-01-27, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2022-11-28, S. 1-6Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2021-11-01, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2021-07-28, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2021-04-21, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2021-02-08, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2020-11-05, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2019-11-24, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2019-11-10, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2018-06-11, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2018-04-25, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2017-08-18, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2017-06-16, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2016-05-19, S. 1-8Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2015, S. 1-8Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc.: Focus on Ultra-Rare Diseases as a Revenue & Profit Driver, 2013, S. 1-23Online reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-12-01), Heft 12, S. 13-16Online reportZugriff: